Innspill til Perspektivmeldingen
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 278 entries.
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
We participated in the influential technology conference SXSW2021.
OCC Accelerator will help start-ups in cancer innovation succeed.
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.